Heart Attack News and Research

RSS

Bretylium tosylate has unique benefits for patients with acute myocardial infarction

An "old" drug has unique benefits for patients with acute myocardial infarction (AMI; commonly known as heart attack), a finding that may contribute to a new understanding of how heart attacks develop, according to an article in the September/October American Journal of Therapeutics.

10 Nov 2004

Calcium channel blocker reduces adverse cardiovascular events

The calcium channel blocker amlodipine decreases the risk of cardiovascular events (such as heart attack or heart-disease related deaths) in patients with coronary artery disease and normal blood pressure, as does the ACE inhibitor enalapril, but to a lesser extent, according to a study in the November 10 issue of JAMA.

10 Nov 2004

Medicare to reimburse preventive cholesterol screening

As the nation's leading cardiologists gather for the American Heart Association's Scientific Sessions 2004, the Centers for Medicare & Medicaid Service (CMS) has announced the 2005 Physician Fee Schedule, which guarantees access to preventive cholesterol screenings for 39 million Medicare-eligible beneficiaries.

9 Nov 2004

Scientists have developed a fast and safe method for collecting heart stem cells from small amounts of biopsied heart tissue

In human and animal studies, scientists at Johns Hopkins have developed a fast and safe method for collecting heart stem cells from remarkably small amounts of biopsied heart tissue (15 mg or less), and growing the cells in the lab to get more.

9 Nov 2004

ACE inhibitors not needed for many heart disease patients

Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) inhibitors, according to results of a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).

8 Nov 2004

Generic statin drugs shown to produce similar or better results than expensive brand-name drugs

Researchers from Kaiser Permanente's Northern California region are presenting a study at this week's American Heart Association Scientific Sessions showing that patients who use a generic statin drug rather than its brand-name equivalent fared as well as- sometimes better than-patients on the more expensive drug.

8 Nov 2004

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

A major Canadian-led global study has found that an inexpensive anti-blood-clotting drug significantly reduces death and repeat heart attacks without increasing the risk of stroke.

8 Nov 2004

People active in their 50s and 60s about 35 percent less likely to die in the next eight years

A new study gives people in their 50s and 60s another reason to get off the couch and be physically active — especially if they have conditions or habits that endanger their hearts, like diabetes, high blood pressure or smoking.

8 Nov 2004

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

This technology has demonstrated the ability to assess an individual's relative risk for heart attack by measuring the person's degree of aspirin resistance.

8 Nov 2004

Obese and overweight men spend 3.5 times more on prescription drugs than normal-weight men

As middle-aged men’s weight goes up, so do their monthly costs for prescription drugs to treat heart disease risk factors and weight-related conditions, according to research presented at the American Heart Association’s Scientific Sessions 2004.

8 Nov 2004

Coronary stents have no impact on mortality over the long term

While the placement of stents in newly reopened coronary arteries has been shown to reduce the need for repeat angioplasty procedures, researchers from the Duke Clinical Research Institute have found that stents have no impact on mortality over the long term.

8 Nov 2004

Atenolol beta-blocker may not be effective in reducing heart attacks

A study published in this weeks issue of THE LANCET suggest that atenolol - one of the most widely prescribed beta-blockers for reducing blood pressure - may not be effective in reducing heart attacks or death from cardiovascular causes.

5 Nov 2004

Vioxx linked with risk of cardiovascular disease

With the support of the National Research Programme (Musculoskeletal Health - Chronic Pain) , researchers at the University of Berne analysed the data in publicly available studies on the anti-inflammatory drug Vioxx.

5 Nov 2004

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

4 Nov 2004

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.

4 Nov 2004

A British first, patient receives heart pump through groin, avoiding the need for surgery

A patient at Hammersmith Hospitals NHS Trust has become the first in the UK to receive an artificial heart pump inserted without the need for surgery.

4 Nov 2004

High-dose statin therapy for aggressive cholesterol-lowering outperforms typical care

Patients treated with high doses of atorvastatin had about a one percent lower annual rate of heart attacks than similar patients receiving usual care, according to a new study in the Nov. 2, 2004 issue of the Journal of the American College of Cardiology.

2 Nov 2004

Do cholesterol-reducing drugs decrease the risk of heart attacks and strokes in diabetics?

International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology’s 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.

1 Nov 2004

Controversial theory about how diabetes causes extensive tissue damage

A controversial theory about how diabetes causes extensive tissue damage will appear in the November issue of Diabetes. At stake in the heated debate over the theory are researchers' efforts to find new ways to reduce loss of vision, kidney failure, heart damage and other side effects of diabetes.

29 Oct 2004

100,000 Iraqi civilians have died as a result of the March 2003 invasion

Public-health experts from the USA and Iraq estimate that around 100,000 Iraqi civilians have died as a result of the March 2003 invasion-the majority being violent deaths among women and children relating to military activity.

29 Oct 2004

Heart Attack News and Research

Bretylium tosylate has unique benefits for patients with acute myocardial infarction

Calcium channel blocker reduces adverse cardiovascular events

Medicare to reimburse preventive cholesterol screening

Scientists have developed a fast and safe method for collecting heart stem cells from small amounts of biopsied heart tissue

ACE inhibitors not needed for many heart disease patients

Generic statin drugs shown to produce similar or better results than expensive brand-name drugs

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

People active in their 50s and 60s about 35 percent less likely to die in the next eight years

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

Obese and overweight men spend 3.5 times more on prescription drugs than normal-weight men

Coronary stents have no impact on mortality over the long term

Atenolol beta-blocker may not be effective in reducing heart attacks

Vioxx linked with risk of cardiovascular disease

Vaccine contributions to health highlighted at PAHO meeting

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

A British first, patient receives heart pump through groin, avoiding the need for surgery

High-dose statin therapy for aggressive cholesterol-lowering outperforms typical care

Do cholesterol-reducing drugs decrease the risk of heart attacks and strokes in diabetics?

Controversial theory about how diabetes causes extensive tissue damage

100,000 Iraqi civilians have died as a result of the March 2003 invasion

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News